Parkview Cancer Institute - Fort Wayne Radiation Oncology Associates — Fort Wayne, Indiana

Parkview Cancer Institute - Fort Wayne Radiation Oncology Associates is a clinical research site located in Fort Wayne, Indiana, United States 46845.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Parkview Cancer Institute - Fort Wayne Radiation Oncology Associates has participated in 1 clinical trials.

Therapeutic areas: Glioblastoma Multiforme.

Sponsors: NovoCure Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fort Wayne

Browse all research sites in Indiana · View every site in Fort Wayne

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Parkview Cancer Institute - Fort Wayne Radiation Oncology Associates?

Parkview Cancer Institute - Fort Wayne Radiation Oncology Associates has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Parkview Cancer Institute - Fort Wayne Radiation Oncology Associates conducted?

Parkview Cancer Institute - Fort Wayne Radiation Oncology Associates has 1 clinical trials on record. Their work covers Glioblastoma Multiforme.

Is Parkview Cancer Institute - Fort Wayne Radiation Oncology Associates accredited by Crixeo Clinical Trials?

Parkview Cancer Institute - Fort Wayne Radiation Oncology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Parkview Cancer Institute - Fort Wayne Radiation Oncology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.